The patient' was a 54-year-old female. She had been suffering from Graves's disease since she was 36 years old and had received methimazole continuously, but there was no history of haematuria, abdominal colicky pain, urinary calculi, or administration of allopurinol. Her parents were consanguineous and her sister had chronic thyroiditis. At the age of 49 hypouricaemia was revealed by chance. Her serum uric acid level was only 0 4 mg/dl (0-02 mmolI). On the other hand her urinary excretion of oxypurine, determined by the method of J0rgensen and Poulsen,2 was as high as 320 mg/day on a purine-
SUMMARY A patient with complete deficiency of xanthine oxidise would not be expected to oxidase allopurinol to oxipurinol if allopurinol did not have any alternative metabolic pathway. 400 mg of allopurinol was administered to a patient with xanthine oxidase deficiency, and plasma allopurinol, oxipurinol, hypoxanthine, and xanthine levels were determined serially by the use of high-perfornman9e liquid chromatography (HPLC). Plasma oxipurinol as well as allopurinol was increased after the administration of allopurinol, and oxipurinol reached a maximum level of 13 1 ,u.g/ml at 6 hours after the administration. This was the same pattern as that of normal controls. This result demonstrated the existence of some other oxidising enzyme of allopurinol than xanthine oxidase.
Allopurinol (4-hydroxypyrazolo [3,4- 
Results
The plasma allopurinol and oxipurinol of this patient and healthy controls are shown in Fig. 1 . In the control group the concentration of plasma allopurinol was highest at 2 hours after the oral administration of allopurinol and then rapidly decreased. The concentration of plasma oxipurinol was highest at 8 hours after administration of the allopurinol and then decreased gradually. In the patient the maximum plasma allopurinol level was observed at 14 hours after its administration, after which it rapidly decreased. Oxipurinol increased in the same pattern as that of the controls, reaching the value of 13-1 ,g/ml at 6 hours after administration, of the allopurinol. Plasma hypoxanthine and xanthine concentrations are shown in Fig. 2 . In the controls almost no significant change was seen, but in the patient hypoxanthine was markedly decreased between 6 and 8 hours after the administration of allopurinol, simultaneously with the peak level of plasma oxipurinol. 
